LD 1558 LR 2032(01)
An Act to Prohibit the Sale of Tobacco Products in Pharmacies and Retail Establishments Containing Pharmacies
Preliminary Fiscal Impact Statement for Original Bill
Sponsor: Rep. Moonen of Portland
Committee: Health and Human Services
Fiscal Note Required: Yes
Preliminary Fiscal Impact Statement
FY 2023-24 FY 2024-25 Projections  FY 2025-26 Projections  FY 2026-27
Net Cost (Savings)
General Fund $372,400 $906,650 $918,600 $931,550
General Fund ($372,400) ($906,650) ($918,600) ($931,550)
Other Special Revenue Funds ($2,600) ($6,350) ($6,400) ($6,450)
Correctional and Judicial Impact Statements
Establishes new civil violations. The additional workload associated with the minimal number of new cases filed in the court system does not require additional funding at this time.
The collection of additional fines will increase General Fund or other dedicated revenue by minor amounts.
Fiscal Detail and Notes
This bill prohibits the retail sale of tobacco products in pharmacies and retail establishments containing a pharmacy effective January 1, 2024. It will reduce General Fund revenue from the sales tax, cigarette tax and tobacco products tax by $372,400 in fiscal year 2023-24 and $906,650 in fiscal year 2024-25. The decrease in sales tax revenue will reduce Local Government Fund revenue by $2,600 in fiscal year 2023-24 and $6,350 in fiscal year 2024-25.
Any additional costs to the Department of Health and Human Services to adopt the changes in this bill are expected to be minor and can be absorbed within existing budgeted resources.